Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

PHASE1CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Healthy
Interventions
DRUG

lansoprazole

60 mg (2x30-mg capsule), once daily

DRUG

omeprazole

80 mg (2x40-mg capsule), once daily

DRUG

esomeprazole

40 mg (1x40-mg capsule), once daily

DRUG

clopidogrel

300 mg loading dose on Day 1 then 75 mg daily for 28 days

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY